| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0119221520283057 | 0.33337995 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0119221520283057 | 0.20912086 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0119221520283057 | 0.30885121 |
| NSC 13484 | Null | 0.0119221520283057 | 0.44919093 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0119221520283057 | 0.28514872 |
| NSC 319947 | 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- | 0.0119221520283057 | 0.18600327 |
| NSC 382032 | Null | 0.0119221520283057 | 0.18815292 |
| NSC 608984 | Leucinostatine D | 0.0119221520283057 | 0.043281761 |
| NSC 618770 | Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide | 0.0119221520283057 | 0.44050794 |
| NSC 636984 | Null | 0.0119221520283057 | 0.32627154 |